Pathkey.ai Limited has released a press release.
Pause in Trade
Filed with ASX ·
On 6ix: 6ix.com/news/pause-in-trade-94
6ix hasn’t read this filing yet.
Earlier from Pathkey.AI
- Appendix 4C - monthly
- Cancer Trials Australia becomes MediaConsent collaborator
- Capital Raise and Strategic Acquisition of Ludomade
- Collaboration announced with Neuroscience Trials Australia
- SRO partners with Secure One Button Login experts SAAVHA
Later from Pathkey.AI
- Changes to Board of Directors
- Reinstatement to Trading on the ASX
- Half Year Financial Report & Appendix 4D
- Michelle Gallaher appointed SRO CEO
- Response to Appendix 4C Query
Follow Pathkey.AI into a list and get an email when it puts out news.
Follow Pathkey.AI